ENBREL for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 2,992 adverse event reports in the FDA FAERS database where ENBREL was used for Psoriasis.
Most Reported Side Effects for ENBREL
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Injection site pain | 2,386 | 13.3% | 0 | 83 |
| Arthralgia | 2,102 | 11.7% | 4 | 261 |
| Injection site erythema | 1,879 | 10.5% | 2 | 41 |
| Pain in extremity | 1,381 | 7.7% | 1 | 156 |
| Pain | 1,240 | 6.9% | 5 | 154 |
| Injection site swelling | 1,121 | 6.3% | 2 | 26 |
| Psoriasis | 1,100 | 6.1% | 1 | 93 |
| Injection site pruritus | 1,026 | 5.7% | 0 | 20 |
| Injection site reaction | 933 | 5.2% | 1 | 30 |
| Drug ineffective | 925 | 5.2% | 5 | 77 |
| Injection site bruising | 854 | 4.8% | 0 | 25 |
| Headache | 790 | 4.4% | 1 | 53 |
| Fatigue | 782 | 4.4% | 1 | 70 |
| Nasopharyngitis | 777 | 4.3% | 2 | 48 |
| Joint swelling | 696 | 3.9% | 1 | 101 |
Other Indications for ENBREL
Rheumatoid arthritis (9,897)
Psoriatic arthropathy (2,729)
Product used for unknown indication (1,738)
Ankylosing spondylitis (1,032)
Juvenile idiopathic arthritis (268)
Arthritis (72)
Osteoarthritis (26)
Pustular psoriasis (16)
Arthritis reactive (15)
Systemic lupus erythematosus (13)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)